1. Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359-386 (2015).
2. Kim, B. W. et al. Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database. Gut Liver 13, 104-113 (2019).
3. Wi, Y., Woo, H., Won, Y. J., Jang, J. Y. & Shin, A. Trends in Gallbladder Cancer Incidence and Survival in Korea. Cancer Res Treat 50, 1444-1451 (2018).
4. Hickman, L. & Contreras, C. Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies. Surg Clin North Am 99, 337-355 (2019).
5. Hiroshima, Y. et al. Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system. J Laparoendosc Adv Surg Tech A 24, 241-247 (2014).
6. Ahmad, A. Use of indocyanine green (ICG) augmented near-infrared fluorescence imaging in robotic radical resection of gallbladder adenocarcinomas. Surg Endosc 34, 2490-2494 (2020).
7. van der Vorst, J. R. et al. Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer 119, 3411-3418 (2013).
8. Yoon, Y. S. et al. Is Laparoscopy Contraindicated for Gallbladder Cancer? A 10-Year Prospective Cohort Study. J Am Coll Surg 221, 847-853 (2015).
9. Shirobe, T. & Maruyama, S. Laparoscopic radical cholecystectomy with lymph node dissection for gallbladder carcinoma. Surg Endosc 29, 2244-2250 (2015).
10. Shenoy, R. et al. Intraoperative and postoperative outcomes of robot-assisted cholecystectomy: a systematic review. Syst Rev 10, 124 (2021).
11. Dip, F. D., Ishizawa, T., Kokudo, N. & Rosenthal, R. J. Fluorescence Imaging for Surgeons : Concepts and Applications 1st edn 1 online resource (XXI, 360 pages 196 illustrations, 154 illustrations in color (Springer International Publishing : Imprint: Springer,, 2015).
12. Wendler, T., van Leeuwen, F. W. B., Navab, N. & van Oosterom, M. N. How molecular imaging will enable robotic precision surgery : The role of artificial intelligence, augmented reality, and navigation. Eur J Nucl Med Mol Imaging 48, 4201-4224 (2021).
13. Hernot, S., van Manen, L., Debie, P., Mieog, J. S. D. & Vahrmeijer, A. L. Latest developments in molecular tracers for fluorescence image-guided cancer surgery. Lancet Oncol 20, e354-e367 (2019).
14. Sigismund, S., Avanzato, D. & Lanzetti, L. Emerging functions of the EGFR in cancer. Mol Oncol 12, 3-20 (2018).
15. Das, C., Mukhopadhyay, M., Subba, S., Saha, A. K. & Mukhopadhyay, B. Role of EGFR and HER-2/NEU Expression in Gall Bladder Carcinoma (GBC). J Lab Physicians 13, 29-35 (2021).
16. Kaufman, M. et al. EGFR expression in gallbladder carcinoma in North America. Int J Med Sci 5, 285-291 (2008).
17. Kang, C. M. et al. Laparoscopic cholecystectomy only could be an appropriate treatment for selected clinical R0 gallbladder carcinoma. Surg Endosc 21, 1582-1587 (2007).
18. Kang, C. M. et al. Does "clinical" R0 have validity in the choice of simple cholecystectomy for gallbladder carcinoma? J Gastrointest Surg 11, 1309-1316 (2007).
19. Lee, H. et al. Optimal extent of surgery for early gallbladder cancer with regard to long-term survival: a meta-analysis. J Hepatobiliary Pancreat Sci 25, 131-141 (2018).
20. Kang, H. et al. Prognostic Significance of Tumor Location in T2 Gallbladder Cancer: A Systematic Review and Meta-Analysis. J Clin Med 10 (2021).
21. Lee, S. E. et al. Practical guidelines for the surgical treatment of gallbladder cancer. J Korean Med Sci 29, 1333-1340 (2014).
22. Rosenthal, E. L. et al. Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer. Clin Cancer Res 21, 3658-3666 (2015).
23. Tummers, W. S. et al. Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging. Ann Surg Oncol 25, 1880-1888 (2018).
24. Miller, S. E. et al. First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800. J Neurooncol 139, 135-143 (2018).
25. van Keulen, S. et al. Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma. Oral Oncol 88, 58-65 (2019).
26. Zhou, Q. et al. EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial. Theranostics 11, 7130-7143 (2021).
27. Marston, J. C. et al. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer. J Surg Res 239, 44-51 (2019).
28. Doval, D. C., Azam, S., Sinha, R., Batra, U. & Mehta, A. Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma. J Carcinog 13, 10 (2014).
29. Hoogstins, C. E. et al. A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer. Clin Cancer Res 22, 2929-2938 (2016).
30. Harlaar, N. J. et al. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study. Lancet Gastroenterol Hepatol 1, 283-290 (2016).
31. Boogerd, L. S. F. et al. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study. Lancet Gastroenterol Hepatol 3, 181-191 (2018).
32. Smith, B. L. et al. Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity walls using a novel cathepsin-activated fluorescent imaging system. Breast Cancer Res Treat 171, 413-420 (2018).
33. Unkart, J. T. et al. Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study. Ann Surg Oncol 24, 3167-3173 (2017).
34. Lee, N. P., Chan, C. M., Tung, L. N., Wang, H. K. & Law, S. Tumor xenograft animal models for esophageal squamous cell carcinoma. J Biomed Sci 25, 66 (2018).
35. Mita, Y. et al. Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice. Ann Surg Oncol 14, 1374-1380 (2007).